These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19583774)

  • 21. Yellow fever virus NS2B-NS3 protease: charged-to-alanine mutagenesis and deletion analysis define regions important for protease complex formation and function.
    Droll DA; Krishna Murthy HM; Chambers TJ
    Virology; 2000 Sep; 275(2):335-47. PubMed ID: 10998334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
    Samanta S; Lim TL; Lam Y
    ChemMedChem; 2013 Jun; 8(6):994-1001. PubMed ID: 23619931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y; Samanta S; Cui T; Lam Y
    ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
    Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
    Ang MJ; Lim HA; Poulsen A; Wee JL; Ng FM; Joy J; Hill J; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(sup2):194-200. PubMed ID: 27241372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.
    Zuo Z; Liew OW; Chen G; Chong PC; Lee SH; Chen K; Jiang H; Puah CM; Zhu W
    J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
    Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
    Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.
    Tomlinson SM; Watowich SJ
    Biochemistry; 2008 Nov; 47(45):11763-70. PubMed ID: 18855422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
    Huang D
    Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
    Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
    Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
    J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: a P3 and N-cap optimization study.
    Lim HA; Ang MJ; Joy J; Poulsen A; Wu W; Ching SC; Hill J; Chia CS
    Eur J Med Chem; 2013 Apr; 62():199-205. PubMed ID: 23353753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
    Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease.
    Lin CW; Huang HD; Shiu SY; Chen WJ; Tsai MH; Huang SH; Wan L; Lin YJ
    Virus Res; 2007 Jul; 127(1):88-94. PubMed ID: 17467838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region.
    Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
    Protein Expr Purif; 2007 Apr; 52(2):334-9. PubMed ID: 17189703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.